Diagnostic Code 8014 · 38 CFR §4.124a
Meningovascular syphilis is the form of late-stage neurosyphilis in which the inflammation involves the small and medium arteries supplying the brain and spinal cord, producing a vasculitis pattern that leads to strokes, transient ischemic attacks, and focal neurological deficits. Clinically it can resemble a hypertensive or atherosclerotic stroke, but the underlying mechanism is syphilitic inflammation of the arterial wall (Heubner endarteritis) rather than atherothrombotic disease. Veterans with meningovascular syphilis typically present with sudden-onset stroke-like neurological deficits that occur years or decades after the original untreated syphilis infection. Treatment with intravenous penicillin halts further vasculitic damage, but the strokes that have already occurred leave permanent neurological residuals. The VA rates DC 8014 with the same protected 30% minimum framework as the other neurosyphilis codes, with higher tiers driven by the severity of the post-stroke residuals.
| Rating | Criteria |
|---|---|
| 30% | Minimum schedular evaluation for any confirmed meningovascular syphilis diagnosis, regardless of current symptom severity. |
| 60% | Moderate residuals — definite focal neurological deficits from one or more strokes (hemiparesis, sensory loss, speech impairment, visual field deficits), with measurable functional limitation in daily activity. |
| 80% | Severe residuals — substantial focal neurological deficits (significant hemiparesis, aphasia, hemianopia), or multiple strokes producing cumulative impairment. |
| 100% | Total impairment — catastrophic residuals (severe hemiparesis or hemiplegia with associated cognitive impairment, complete aphasia, bilateral neurological involvement), requirement for aid and attendance. Special Monthly Compensation applies based on the specific functional losses. |
Serology (RPR/VDRL with confirmatory FTA-ABS or TP-PA) establishes the syphilis diagnosis. CSF analysis with elevated protein, lymphocytic pleocytosis, and positive CSF VDRL confirms CNS involvement. MRI or CT angiography of the brain shows the characteristic arteritic pattern — focal narrowing of small and medium cerebral arteries — distinguishing meningovascular syphilis from atherosclerotic stroke. Stroke imaging documents the location and extent of each ischemic lesion. Neurological examination characterizes the residual deficits from each stroke event. Penicillin treatment records confirm appropriate antibiotic therapy. Service medical records establishing in-service syphilis exposure support direct service connection.
The distinguishing features are: (1) serology and CSF VDRL confirming syphilis with CNS involvement; (2) angiographic imaging showing the characteristic small-vessel arteritis pattern rather than the large-vessel atherosclerotic pattern; (3) age and risk-factor profile (meningovascular syphilis can produce stroke in younger patients without the typical cardiovascular risk factors); and (4) treatment response — intravenous penicillin halts further events in meningovascular syphilis. A neurology consult plus serology is the standard diagnostic workup.
Yes. Each stroke produces its own residuals — focal deficits, cognitive impact, functional limitations — and the rating reflects the cumulative impact. Multiple stroke events with cumulative deficits typically warrant the 80% or 100% tier under DC 8014. The principle is that the rating captures the total functional impairment, not just the most recent event.
Intravenous penicillin halts the progression of vasculitis and prevents further strokes, but it does not reverse damage from strokes that have already occurred. The neurological deficits present at the time of treatment generally persist as permanent residuals. Rehabilitation may produce some functional improvement over the first year, but plateau is typical thereafter, and the rating reflects the post-rehabilitation steady state.